Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
TLSI
#3452
TriSalus Life Sciences, Inc. Common Stock
4.4
0
USD
+1.15%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.15%
Changement Mensuel
+6.80%
Evolution sur 6 mois
-5.98%
Changement Annuel
-20.72%
Clôture Précédente
4.3
5
Open
4.4
0
Bid
Ask
Low
4.4
0
High
4.4
0
Volume
20
Marchés
Actions des Marchés US
Soins de Santé
TLSI
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
31.25 M
8.2 M
26.76 M
32.27 M
61.31 M
—
Valuation ratios
Enterprise value
—
—
208.98 M
175.32 M
440.56 M
1.19 B
Price to earnings ratio
—
—
-1.23
-3.82
-3.79
-15.83
Price to sales ratio
—
—
4.19
4.31
5.86
18.34
Price to cash flow ratio
—
—
-1.55
-3.11
-14.69
-30.86
Price to book ratio
—
—
-2.99
-4.9
-7.81
-12.06
Enterprise value to EBITDA ratio
—
—
-22.78
21.74
27.17
-818.52
Profitability ratios
Return on assets %
0.02
0.27
-2.29
-1.25
-1.11
-1.14
Return on equity %
-0.29
-0.42
2.28
1.16
1.16
1.42
Return on invested capital %
-4.87
-7.31
-1 552.65
-2 533.96
-2 243.33
-2 276.77
Gross margin %
—
—
85.93
86.06
84.57
337.8
Operating margin %
—
—
-292.53
-122.88
-59.68
-248.04
EBITDA margin %
—
—
-49.55
27.61
36.01
-34.85
Net margin %
—
—
-318.93
-102.09
-86.88
-354.42
Liquidity ratios
Quick ratio
—
—
1.25
1.63
2.54
10.75
Current ratio
0.5
0.14
1.42
2.02
2.8
12.08
Inventory turnover
—
—
1.02
1.24
1.96
1.91
Asset turnover
—
—
0.81
1.18
1.52
1.33
Solvency ratios
Debt to assets ratio
—
—
—
0.92
0.94
3.72
Debt to equity ratio
—
—
—
-0.86
-0.98
-4.79
Long term debt to total assets ratio
—
—
—
0.92
0.94
3.72
Long term debt to total equity ratio
—
—
—
-0.85
-0.98
-4.79
Per share metrics
Operating cash flow per share
-0.06
-0.09
-5.33
-1.61
-0.48
-0.53
EBIT per share
—
—
-1.05
0.24
0.38
-0.12
EBITDA per share
—
—
-0.98
0.32
0.43
-0.07
Total debt per share
—
—
—
0.87
0.87
3.73
Cash per share
0.01
0.01
1.25
0.34
0.54
2.33
Net current asset value per share
0.02
0.01
2.22
0.82
0.85
3.66
Tangible book value per share
-0.53
-0.45
-2.88
-1.02
-0.89
-3.31
Working capital per share
-0.02
-0.07
0.66
0.41
0.55
2.41
Book value per share
-0.53
-0.45
-2.76
-1.02
-0.89
-3.31
Nouvelles
TriSalus présentera des données sur l’administration de médicaments
TriSalus nomme Richard Marshall au poste de directeur médical
TriSalus publie des données précliniques sur sa technologie d’administration de médicaments
Jones Trading réitère sa recommandation d’achat sur TriSalus Life Sciences après les résultats
Jones Trading reiterates Buy on TriSalus Life Sciences stock after earnings
TriSalus Life Sciences, Inc. (TLSI) Q4 2025 Earnings Call Transcript
TriSalus Life Sciences enregistre une hausse de 60% de son chiffre d’affaires au T4
Earnings call transcript: TriSalus Life Sciences sees 60% Q4 revenue rise
TriSalus fixe le prix d’une offre publique de 40 M$ à 4,10$ par action
TriSalus prices $40M public offering at $4.10 per share
TriSalus Life Sciences appoints Michael Stansky to board of directors
TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know